Buy & Sell Novo Nordisk A/S (NVO) – Novo Nordisk A/S Price Today
Aura AI Summary
Key Stats
- $206.93BMarket Cap
- HealthSector
- -25.58%3M Drawdown
- $226.39BEnterprise Value
- 4.07%Dividend Yield
- 98% Buy | 2% SellTrading Activity
- 101 daysTypical Hold Time
Novo Nordisk A/S (NVO) is currently valued at a market capitalization of $206.93B, with an enterprise value of $226.39B. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $81.05, highlighting its annual price range. Over the past three months, Novo Nordisk A/S has recorded a drawdown of -25.58%, reflecting recent price volatility. Novo Nordisk A/S offers a dividend yield of 4.07%, with the most recent dividend of $1.28 paid on 30 Mar 26. On average, investors hold Novo Nordisk A/S for approximately 101 days, indicating typical investor behavior on the platform.
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Most Recent News
Li Auto adopts Arteris tech for AI-powered SoCs in new L9 Livis SUV, boosting autonomous driving capabilities.
Li Auto has integrated Arteris' FlexNoC 5 network-on-chip IP and Magillem software into its proprietary autonomous driving SoCs for the new L9 Livis SUV. This technology supports AI data movement and integration, enabling the vehicle to perform 2,560...

Arteris tech powers Li Auto's new L9 Livis SUV with advanced AI and SoC integration.
Arteris, Inc. announced its system IP technology is adopted by Li Auto for its new L9 Livis flagship SUV, integrating the Mach M100 autonomous driving SoC. This collaboration enhances AI data movement and system efficiency, meeting high performance, ...

Webull launches Vega Analyst, an AI tool for personalized stock research for retail investors.
Webull Corp. has introduced Vega Analyst, an AI-powered research tool that provides customized, real-time stock analysis based on user-selected research areas like fundamentals, valuation, and technical trends. This tool helps investors better unders...
